Skip to content

Public FDA record

Z-1374-2019: SOLOPATH Balloon Expandable TransFemoral System, Model Numbers STFI-1425, STFI-1435, STFI-1625, STFI-1

Recall record Z-1374-2019 for Terumo Medical Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1374-2019
Company in FDA record
Terumo Medical Corporation
FDA classification date
May 28, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

There is a potential for dislodgement of the tip from the outer diameter of the sheath resulting in a loss of the smooth transition from the surface of the tip to the outer surface of the expandable sheath.

Source facts

Action
Urgent Medical Device Recall letters dated 4/26/19 were sent to customers.
Initiated
2019-04-26
Root cause
Device Design
Terminated
2020-09-22
Distribution
The products were distributed US nationwide. The products were distributed to the following foreign countries: Australia, Belgium, Brazil, Canada, Portugal, Hong Kong, Peru, Singapore.
Recall number
Z-1374-2019
Recall status
Terminated
CDRH record ID
172421
FDA classified
2019-05-28
Recall event number
82705

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗